IP Library Granted Patent US 11,166,704
Granted Patent B2
US 11,166,704 · App. 16/002,272 · Granted Nov 9, 2021

Fistula treatment device

Inventors: Eoin Bambury (Galway, IE); Moshe Zilversmit (Campbell, CA)
Assignee: National University of Ireland, Galway
A61B17/0057A61B17/0401A61B17/0469A61B17/064A61B17/068A61B17/08A61M27/002A61B1/31A61B2017/00004A61B2017/00557A61B2017/00641A61B2017/00659A61B2017/00663A61B2017/00867A61B2017/00946A61B2017/0409A61B2017/0412A61B2017/0417A61B2017/0427A61B2017/0441A61B2017/0464A61B2017/0649A61B2017/06052A61B2017/06076A61B2017/06171A61B2017/06176A61B2217/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,166,704
App. No.
16/002,272
Granted
Nov 9, 2021
Kind
B2
Abstract

A fistula treatment system comprises a guide such as a guide coil 1101 which is adapted to extend partially around a tissue tract and an implant element 1102 . The implant element 1102 is activated to draw tissue surrounding the tract inwardly.

Claims (27)

1. A system for treating a fistula, comprising:

an implant having a helical coil portion having (1) a taper portion and (2) a driver interface portion comprising a substantially straight lateral extent; and

an implant driver having a distal end including a helical coil structure having an inner surface and an outer surface, the inner surface defining an unobstructed lumen;

wherein, in a delivery configuration, the distal end of the implant driver is configured to engage a radially outer surface of the driver interface portion of the implant to urge the implant into tissue while a radially interior surface of the implant is free from contact with the implant driver.

2. The system of claim 1 , wherein in the delivery configuration, the radially interior surface of the implant is free to directly contact tissue.

3. The system of claim 1 , wherein the taper portion is defined by the radially interior surface of the implant.

4. The system of claim 1 , wherein the taper portion tapers toward a proximal end of the implant, and the taper portion is located distal of the driver interface portion.

5. The system of claim 1 , wherein the implant is bioabsorable.

6. A system for treating a fistula, comprising:

an implant having a helical coil portion having (1) a taper portion and (2) a driver interface portion comprising a substantially straight lateral extent; and

an implant driver having a distal end including a helical coil structure having an inner surface and an outer surface, the inner surface defining an unobstructed lumen, wherein a maximum lateral extent of the implant driver is less than a maximum lateral extent of the implant;

wherein, in a driver engaged configuration, the distal end of the implant driver is configured to engage the driver interface portion of the implant to urge the implant into tissue.

7. The system of claim 6 , wherein, in the driver engaged configuration, an interior surface of the implant is free from contact with the implant driver.

8. The system of claim 6 , wherein the distal end of the implant driver surrounds an outer portion of the implant in the driver engaged configuration.

9. The system of claim 6 , wherein the helical coil structure of the implant driver and the helical coil portion of the implant have a common pitch.

10. The system of claim 6 , wherein the implant comprises one or more barbs to prevent rewind of the implant in tissue, and

wherein the one or more barbs form the maximum lateral extent of the implant.

11. The system of claim 6 , wherein the taper portion tapers toward a proximal end of the implant and the taper portion is located distal of the driver interface portion.

12. The system of claim 6 , wherein the taper portion of the implant is defined by an interior surface of the implant.

13. A system for treating a fistula, comprising:

an implant having a helical coil portion having (1) a taper portion and (2) a driver interface portion comprising a substantially straight lateral extent; and

an implant driver having a distal end including a helical coil structure having an inner surface and an outer surface, the inner surface defining an unobstructed lumen, wherein a maximum lateral extent of the implant driver is less than a maximum lateral extent of the implant,

wherein, in a delivery configuration, the distal end of the implant driver is configured to engage a radially outer surface of the driver interface portion of the implant to urge the implant into tissue, while a radially interior surface of the driver interface portion is free from contact with the implant driver.

14. The system of claim 13 , wherein the substantially straight lateral extent of the implant includes an abutment, wherein the distal end of the implant driver is configured to engage the abutment to urge the implant into tissue.

15. The system of claim 13 , wherein the implant includes one or more barbs to prevent rewind of the implant in tissue, and

wherein the one or more barbs form the maximum lateral extent of the implant.

16. The system of claim 13 , wherein the helical coil structure of the implant driver and the helical coil of the implant have a common pitch.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2018
From: BAMBURY, EOIN; ZILVERSMIT, MOSHE
To: NATIONAL UNIVERSITY OF IRELAND, GALWAY
Reel/Frame 046272/0049 →
Priority Claims (3)
EP 15169640 · May 28, 2015 · regional
EP 16174951 · Jun 17, 2016 · regional
EP 16201270 · Nov 29, 2016 · regional
Continuity (3)
Continuation 15595619 · May 15, 2017
Continuation In Part PCTEP2016061944 · May 26, 2016
Related Publication 20180344303A1 · Dec 6, 2018